Immunomodulatory peptides: new therapeutic horizons for emerging and re-emerging infectious diseases
2024

Immunomodulatory Peptides for Infectious Diseases

publication Evidence: moderate

Author Information

Author(s): Chatterjee Debolina, Sivashanmugam Karthikeyan

Primary Institution: School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India

Hypothesis

Can host defense peptides (HDPs) serve as effective therapeutic alternatives for treating multi-drug-resistant infections?

Conclusion

Host defense peptides show promise as effective alternatives to traditional antibiotics in managing infectious diseases.

Supporting Evidence

  • Host defense peptides can stimulate or inhibit the immune system.
  • These peptides have been found in various organisms, including humans and plants.
  • Immunomodulatory peptides can enhance wound healing and reduce inflammation.

Takeaway

Some tiny proteins in our body can help fight off infections and might be better than antibiotics for some sick people.

Methodology

The article reviews various studies on the immunomodulatory activities of host defense peptides derived from different eukaryotic organisms.

Potential Biases

Potential bias due to the focus on animal studies and limited human data.

Limitations

Most studies are based on animal models, with limited clinical trials in humans.

Digital Object Identifier (DOI)

10.3389/fmicb.2024.1505571

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication